| View |
2021-04-28-0200
|
HUMAN NORMAL IMMUNOGLOBULIN (IGIV)
|
GAMMA I.V.
|
BR-636
|
A03321002
|
Packaging Lot (Box & Vial): A03321002
|
28 February 2023
|
03 May 2021
|
| View |
2021-06-04-0264
|
BCG VACCINE
|
-
|
BR-572
|
0370G142
|
Packaging lot (Box & Vial): 0370G142; (Diluent): 0700S4017 & 0700S4018
|
28 February 2023
|
08 June 2021
|
| View |
2021-06-04-0266
|
BCG VACCINE
|
-
|
BR-572
|
0370G141
|
Packaging lot (Box & Vial): 0370G141; (Diluent): 0700S4017 & 0700S4018
|
28 February 2023
|
08 June 2021
|
| View |
2021-06-14-0271
|
FOLLITROPIN ALFA
|
GONAL-F
|
BR-830
|
BA071873
|
Packaging Lot (Box & Pre-filled Pen Cartridge): BA071873
|
28 February 2023
|
15 June 2021
|
| View |
2021-06-18-0280
|
INACTIVATED POLIOMYELITIS VACCINE (TYPE 1, 2 AND 3)
|
IMOVAX POLIO
|
BR-929
|
U1B17
|
Packaging Lot (Box): U1B172V; (Vial): U1B17
|
28 February 2023
|
22 June 2021
|
| View |
2021-06-21-0287
|
FOLLITROPIN ALFA
|
GONAL-F
|
BR-830
|
BA072522
|
Packaging Lot (Box & Pre-filled Pen Cartridge): BA072522
|
28 February 2023
|
23 June 2021
|
| View |
2021-06-23-0290
|
EPOETIN BETA
|
RECORMON
|
BR-1091
|
H1002
|
Packaging Lot (Box & PFS): H1002H04
|
28 February 2023
|
25 June 2021
|
| View |
2021-06-29-0303
|
BEVACIZUMAB
|
AVASTIN
|
BR-969
|
B7269
|
Packaging Lot (Box): B7269B16
|
28 February 2023
|
30 June 2021
|
| View |
2021-07-14-0342
|
INACTIVATED POLIOMYELITIS VACCINE (TYPES 1, 2 AND 3)
|
IMOVAX POLIO
|
BR-498
|
U3D66
|
Packaging Lot (Box): U3D667V; (Pre-filled Syringe): U3D66
|
28 February 2023
|
16 July 2021
|
| View |
2021-07-26-0367
|
EPOETIN BETA
|
RECORMON
|
BRP-084
|
H1001
|
Packaging Lot (Box): H1001H04
|
28 February 2023
|
28 July 2021
|
| View |
2021-07-26-0368
|
EPOETIN BETA
|
RECORMON
|
BR-1091
|
H1003
|
Packaging Lot (Box): H1003H02
|
28 February 2023
|
28 July 2021
|
| View |
2021-07-28-0379
|
VI-POLYSACCHARIDE TYPHOID VACCINE
|
TYPHIM VI
|
BR-280
|
U2A10
|
Packaging Lot (Box): U2A102V; (PFS): U2A10
|
28 February 2023
|
30 July 2021
|
| View |
2021-08-13-0429
|
RECOMBINANT B-SUBUNIT/INACTIVATED WHOLE CELL CHOLERA VACCINE
|
ORAVACS
|
FDA-0497597
|
202103P07
|
Packaging Lot (Box & Vial): C235090P01
|
28 February 2023
|
17 August 2021
|
| View |
2021-07-28-0375
|
INFLIXIMAB
|
REMICADE
|
BR-1095
|
LCM17013A
|
Packaging Lot (Box): LCM17013; (Vial): LCM17013
|
28 February 2024
|
30 July 2021
|
| View |
2022-06-10-0144
|
ANTITHYMOCYTE IMMUNOGLOBULIN (ATG) (EQUINE)
|
THYMOGAM
|
BR-628
|
A05422001
|
Packaging Lot (Box & Vial): A05422001
|
28 February 2024
|
15 June 2022
|
| View |
2022-07-07-0176
|
ANTI-RABIES SERUM (EQUINE)
|
EQUIRAB
|
BR-676
|
A06822007
|
Packaging Lot (Box Vial): A06822007
|
28 February 2024
|
12 July 2022
|
| View |
2022-10-20-0303
|
HEPATITIS B VACCINE (rDNA)
|
GENVAC-B
|
BR-567
|
0322Q005E
|
Packaging Lot (Box & Vial): 0322Q005E
|
28 February 2025
|
25 October 2022
|
| View |
2020-04-27-0085
|
Quadrivalent Seasonal Influenza Vaccine (Inactivated, Types A & B Subvirion) 2020 Southern Hemisphere Strain
|
Fluquadri
|
BR-1084
|
U6873
|
Packaging Lot (box & pre-filled syringe): UJ369AB; Needle – 200219C; ED: 2025-01-31
|
28 January 2021
|
28 April 2020
|
| View |
2018-12-14-0301
|
Recombinant Hepatitis B Vaccine
|
Euvax B (Adult) - Preservative Free
|
BR-714
|
UFX18007
|
Packaging Lot: Box & Vial - UFX18007; MD: 29 June 2018; ED: 28 June 2021
|
28 June 2021
|
19 December 2018
|
| View |
2020-02-17-0037
|
Pneumococcal Polysaccharide Vaccine, Polyvalent
|
Pneumovax 23
|
BR-1147
|
1005230
|
Packaging lot (box and pfs): S039081
|
28 June 2021
|
18 February 2020
|